itek, J.; Candek-Potokar, M.; Djekic, I.; Getya, A.; Guerrero, L.; Ivanova, S.; Kusec, G.; Nakov, D.; et al. Attitudes and beliefs of eastern european consumers towards animal welfare. Animals 2020, 10, 17. [CrossRef] [PubMed] © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Council Directive 2008/120/EC
Filters
itek, J.; Candek-Potokar, M.; Djekic, I.; Getya, A.; Guerrero, L.; Ivanova, S.; Kusec, G.; Nakov, D.; et al. Attitudes and beliefs of eastern european consumers towards animal welfare. Animals 2020, 10, 17. [CrossRef] [PubMed] © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
…According to the Council Directive 2008/120/EC of 18 December 2008 laying down the minimum standards for the protection of pigs, surgical castration can be performed without anesthesia until the seventh…
…According to the Council Directive 2008/120/EC of 18 December 2008 laying down the minimum standards for the protection of pigs, surgical castration can be performed without anesthesia until the seventh…
ry safety and efficacy field trials with the principles of Good Clinical Practice (GCP) as laid down in the Council Directive 2001/82/EC and guideline CVMP/VICH/595/98 VICH Topic…
ry safety and efficacy field trials with the principles of Good Clinical Practice (GCP) as laid down in the Council Directive 2001/82/EC and guideline CVMP/VICH/595/98 VICH Topic…
ry safety and efficacy field trials with the principles of Good Clinical Practice (GCP) as laid down in the Council Directive 2001/82/EC and guideline CVMP/VICH/595/98 VICH Topic…
te the scope, methods, and strength of the evidence supporting each assessment. Boundary Documentation All analyses must clearly define the analytical boundaries, including the Life-Fates (e.g., market animals, breeders, culled individuals), Life-Phases (e.g., rearing, transport, slaughter), Affective Experiences included (e.g., Pain due to injury, Pleasure from social play), and any notable exclusions from the analysis. Evidence Transparency Analyses must provide access to the scientific evidence and methodological justifications used to estimate the intensity and duration of affective experiences. This includes ample documentation and citation of the evidence and knowledge used to support estimates of intensity, duration and prevalence. Uncertainty Representation To avoid overstating precision, all quantitative results (e.g., Cumulative Pain or Pleasure) must be expressed as ranges or probability distributions rather than single-point estimates. This requirement applies to all temporal durations, intensity probabilities, occurrence frequencies, and prevalence estimates. Methodological Documentation Analyses must include or make available all relevant methodological details, including: (i) Pain-Track and Pleasure-Track diagrams, showing time segments and assigned probabilities for each intensity category, (ii) the prevalence estimates and occurrence assumptions used for each Biological Outcome, (iii) any interspecific scaling factors applied (e.g., hedonic capacity corrections), and (iv) all productivity and mortality parameters used in the final Welfare Footprint calculations. Complete Results Presentation 35 Selective reporting is not permitted. All results—including those that may reflect minimal impact or contradict prior expectations—must be disclosed to
…Council Directive 2008/120/EC of 18 December 2008 Laying Down Minimum
…Council Directive 2008/120/EC of 18 December 2008 Laying Down Minimum